Latest Insider Transactions at Moelis & CO (MC)
This section provides a real-time view of insider transactions for Moelis & CO (MC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Moelis & Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Moelis & Co's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 28
2023
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
30
+1.5%
|
-
|
|
Mar 28
2023
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
22
+1.49%
|
-
|
|
Mar 28
2023
|
Laila Worrell |
BUY
Grant, award, or other acquisition
|
Direct |
16
+1.54%
|
-
|
|
Mar 28
2023
|
Laila Worrell |
BUY
Grant, award, or other acquisition
|
Direct |
12
+1.51%
|
-
|
|
Mar 28
2023
|
Yolonda C Richardson Director |
BUY
Grant, award, or other acquisition
|
Direct |
28
+1.5%
|
-
|
|
Mar 28
2023
|
Yolonda C Richardson Director |
BUY
Grant, award, or other acquisition
|
Direct |
22
+1.54%
|
-
|
|
Mar 28
2023
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
10
+1.5%
|
-
|
|
Mar 28
2023
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
28
+1.5%
|
-
|
|
Mar 28
2023
|
John A Allison |
BUY
Grant, award, or other acquisition
|
Direct |
22
+1.54%
|
-
|
|
Mar 03
2023
|
Navid Mahmoodzadegan Co-President, MD |
SELL
Open market or private sale
|
Direct |
23,323
-18.93%
|
$1,002,889
$43.05 P/Share
|
|
Mar 01
2023
|
Navid Mahmoodzadegan Co-President, MD |
SELL
Open market or private sale
|
Direct |
54,009
-30.48%
|
$2,322,387
$43.13 P/Share
|
|
Feb 28
2023
|
Navid Mahmoodzadegan Co-President, MD |
SELL
Open market or private sale
|
Direct |
52,209
-22.76%
|
$2,244,987
$43.22 P/Share
|
|
Feb 27
2023
|
Osamu R. Watanabe General Counsel, Secretary |
SELL
Open market or private sale
|
Direct |
6,130
-97.91%
|
$257,460
$42.99 P/Share
|
|
Feb 23
2023
|
Kenneth Moelis Chairman, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
80
+0.08%
|
-
|
|
Feb 23
2023
|
Joseph Simon Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,181
-48.71%
|
$427,602
$42.06 P/Share
|
|
Feb 23
2023
|
Joseph Simon Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,901
+50.0%
|
-
|
|
Feb 23
2023
|
Christopher Callesano Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,087
-51.1%
|
$45,654
$42.06 P/Share
|
|
Feb 23
2023
|
Christopher Callesano Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,127
+50.0%
|
-
|
|
Feb 23
2023
|
Eric Cantor Vice Chairman, MD |
SELL
Payment of exercise price or tax liability
|
Direct |
19,144
-10.13%
|
$804,048
$42.06 P/Share
|
|
Feb 23
2023
|
Eric Cantor Vice Chairman, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
43,294
+18.64%
|
-
|
|
Feb 22
2023
|
Kenneth Moelis Chairman, CEO |
SELL
Open market or private sale
|
Direct |
45,507
-31.65%
|
$1,911,294
$42.06 P/Share
|
|
Feb 22
2023
|
Kenneth Moelis Chairman, CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
19,798
-12.1%
|
$831,516
$42.06 P/Share
|
|
Feb 22
2023
|
Kenneth Moelis Chairman, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
113,769
+41.02%
|
-
|
|
Feb 22
2023
|
Jeffrey Raich Co-President, MD |
SELL
Open market or private sale
|
Direct |
36,592
-45.01%
|
$1,536,864
$42.06 P/Share
|
|
Feb 22
2023
|
Jeffrey Raich Co-President, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
91,481
+39.43%
|
-
|
|
Feb 22
2023
|
Jeffrey Raich Co-President, MD |
SELL
Payment of exercise price or tax liability
|
Direct |
10,179
-17.4%
|
$427,518
$42.06 P/Share
|
|
Feb 22
2023
|
Elizabeth Crain |
SELL
Open market or private sale
|
Direct |
10,419
-48.25%
|
$437,598
$42.06 P/Share
|
|
Feb 22
2023
|
Elizabeth Crain |
SELL
Payment of exercise price or tax liability
|
Direct |
4,456
-17.1%
|
$187,152
$42.06 P/Share
|
|
Feb 22
2023
|
Elizabeth Crain |
BUY
Exercise of conversion of derivative security
|
Direct |
26,051
+50.0%
|
-
|
|
Feb 22
2023
|
Navid Mahmoodzadegan Co-President, MD |
SELL
Open market or private sale
|
Direct |
68,561
-23.01%
|
$2,879,562
$42.06 P/Share
|
|
Feb 22
2023
|
Navid Mahmoodzadegan Co-President, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
171,406
+23.54%
|
-
|
|
Feb 22
2023
|
Navid Mahmoodzadegan Co-President, MD |
SELL
Payment of exercise price or tax liability
|
Direct |
19,240
-7.51%
|
$808,080
$42.06 P/Share
|
|
Feb 22
2023
|
Osamu R. Watanabe General Counsel, Secretary |
SELL
Open market or private sale
|
Direct |
5,716
-47.72%
|
$240,072
$42.06 P/Share
|
|
Feb 22
2023
|
Osamu R. Watanabe General Counsel, Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
2,446
-16.96%
|
$102,732
$42.06 P/Share
|
|
Feb 22
2023
|
Osamu R. Watanabe General Counsel, Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
14,292
+49.77%
|
-
|
|
Feb 13
2023
|
Christopher Callesano Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,155
-100.0%
|
$53,130
$46.92 P/Share
|
|
Feb 13
2023
|
Jeffrey Raich Co-President, MD |
SELL
Open market or private sale
|
Direct |
17,183
-100.0%
|
$773,235
$45.08 P/Share
|
|
Feb 10
2023
|
Jeffrey Raich Co-President, MD |
SELL
Open market or private sale
|
Direct |
38,074
-43.73%
|
$1,675,256
$44.58 P/Share
|
|
Feb 09
2023
|
Eric Cantor Vice Chairman, MD |
SELL
Payment of exercise price or tax liability
|
Direct |
1,005
-0.68%
|
$47,235
$47.06 P/Share
|
|
Feb 09
2023
|
Eric Cantor Vice Chairman, MD |
BUY
Exercise of conversion of derivative security
|
Direct |
2,283
+1.53%
|
-
|
|
Feb 09
2023
|
Jeffrey Raich Co-President, MD |
SELL
Open market or private sale
|
Direct |
42,637
-43.55%
|
$1,918,665
$45.3 P/Share
|
|
Jan 31
2023
|
Kenneth Moelis Chairman, CEO |
SELL
Open market or private sale
|
Indirect |
44,676
-100.0%
|
$2,055,096
$46.12 P/Share
|
|
Jan 30
2023
|
Kenneth Moelis Chairman, CEO |
SELL
Open market or private sale
|
Indirect |
60,093
-57.36%
|
$2,764,278
$46.12 P/Share
|
|
Jan 27
2023
|
Kenneth Moelis Chairman, CEO |
SELL
Open market or private sale
|
Indirect |
73,976
-41.39%
|
$3,402,896
$46.18 P/Share
|
|
Jan 24
2023
|
Kenneth Moelis Chairman, CEO |
SELL
Open market or private sale
|
Indirect |
2,368
-1.31%
|
$108,928
$46.02 P/Share
|
|
Jan 23
2023
|
Kenneth Moelis Chairman, CEO |
SELL
Open market or private sale
|
Indirect |
12,310
-6.36%
|
$566,260
$46.03 P/Share
|
|
Jan 11
2023
|
Laila Worrell |
BUY
Grant, award, or other acquisition
|
Direct |
1,010
+50.0%
|
-
|
|
Jan 11
2023
|
Laila Worrell |
BUY
Grant, award, or other acquisition
|
Direct |
772
+50.0%
|
-
|
|
Dec 02
2022
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
2
+0.89%
|
-
|
|
Dec 02
2022
|
Kenneth Shropshire |
BUY
Grant, award, or other acquisition
|
Direct |
25
+1.27%
|
-
|